RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: pancreatic ductal carcinoma
Accession: DOID:3587
browse the term
Definition: A pancreatic carcinoma located_in the pancreatic duct. (DO)
Synonyms: exact_synonym: Duct Cell Carcinoma of the Pancreas; Pancreas Duct-Cell Carcinoma; Pancreas Duct-Cell Carcinomas; Pancreatic Ductal Carcinomas; ductal carcinoma of the pancreas; malignant neoplasm of duct of Wirsung; pancreatic duct cancer; pancreatic duct cell carcinoma
primary_id: MESH:D021441
xref: ICD10CM:C25.3 ; ICD9CM:157.3
For additional species annotation, visit the
Alliance of Genome Resources .
G
2200002D01Rik
RIKEN cDNA 2200002D01 gene
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:35142956
NCBI chr 7:28,946,946...28,947,892
Ensembl chr 7:28,945,986...28,947,891
G
Ace
angiotensin I converting enzyme
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:17481528
RGD:2325211
NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790
G
Ace2
angiotensin converting enzyme 2
ISO
protein:decreased expression:pancreas
RGD
PMID:19212105
RGD:2325210
NCBI chr X:162,922,338...162,971,414
Ensembl chr X:162,922,328...162,971,416
G
Adam8
a disintegrin and metallopeptidase domain 8
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:17979891
RGD:2325243
NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475
G
Adam9
ADAM metallopeptidase domain 9
disease_progression
ISO
protein:altered localization:cytoplasm
RGD
PMID:14997207
RGD:2325249
NCBI chr 8:25,439,627...25,507,138
Ensembl chr 8:25,439,627...25,506,943
G
Agr2
anterior gradient 2
ISO
mRNA:increased expression:pancreas
RGD
PMID:19609859
RGD:2325659
NCBI chr12:36,042,924...36,054,080
Ensembl chr12:36,042,906...36,054,086
G
Agtr1a
angiotensin II receptor, type 1a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr13:30,520,339...30,566,850
Ensembl chr13:30,520,424...30,566,850
G
Alb
albumin
disease_progression
ISO
RGD
PMID:19011933
RGD:2325677
NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461
G
Anxa2
annexin A2
disease_progression
ISO
mRNA, protein:increased expression, altered localization:pancreas, plasma membrane
RGD
PMID:19260470 PMID:16450333
RGD:2317307 , RGD:2325731
NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077
G
Anxa5
annexin A5
ISO
protein:increased expression:pancreas
RGD
PMID:19488907
RGD:2317538
NCBI chr 3:36,503,072...36,530,036
Ensembl chr 3:36,503,072...36,530,043
G
Anxa8
annexin A8
ISO
mRNA:increased expression:pancreas
RGD
PMID:18223320
RGD:2325735
NCBI chr14:33,807,936...33,822,528
Ensembl chr14:33,807,938...33,822,528
G
Apoc1
apolipoprotein C-I
ISO
RGD
PMID:15876873
RGD:2325793
NCBI chr 7:19,423,405...19,426,584
Ensembl chr 7:19,423,406...19,426,585
G
Arg2
arginase type II
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:23424623
NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075
G
Bmi1
Bmi1 polycomb ring finger oncogene
IEP ISO
protein:increased expression:pancreas protein:increased expression:exocrine pancreas:
RGD
PMID:19585519 PMID:19585519
RGD:9491843 , RGD:9491843
NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440
G
Calr
calreticulin
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15289361
RGD:2326165
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Cbx7
chromobox 7
disease_progression
ISO
protein:decreased expression:pancreas
RGD
PMID:20185297
RGD:9587360
NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320
G
Cckar
cholecystokinin A receptor
ISO
protein:decreased expression:pancreas mRNA:increased expression:pancreatic duct
RGD
PMID:12851875 PMID:9239407
RGD:4110816 , RGD:4110818
NCBI chr 5:53,855,827...53,865,046
Ensembl chr 5:53,855,118...53,865,047
G
Cckbr
cholecystokinin B receptor
ISO
protein:decreased expression:pancreas
RGD
PMID:12851875
RGD:4110816
NCBI chr 7:105,075,201...105,085,546
Ensembl chr 7:105,074,938...105,120,105
G
Ccnd1
cyclin D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17420962
RGD:13462063
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cd40
CD40 antigen
treatment
IDA ISO
protein:increased expression:dendritic cell
RGD
PMID:21436454 PMID:23983255 PMID:20976171
RGD:5490301 , RGD:11522743 , RGD:5490524
NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868
G
Cdk6
cyclin dependent kinase 6
treatment
ISO
human cells in a mouse model
RGD
PMID:24389175
RGD:13782187
NCBI chr 5:3,391,004...3,581,008
Ensembl chr 5:3,391,485...3,581,008
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:17671118
RGD:8662851
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cdkn2a
cyclin dependent kinase inhibitor 2A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24986516
NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890
G
Cldn4
claudin 4
ISO
RGD
PMID:15693851
RGD:2317592
NCBI chr 5:134,973,977...134,975,788
Ensembl chr 5:134,973,973...134,975,788
G
Cxcl11
chemokine (C-X-C motif) ligand 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344
G
Dnmt1
DNA methyltransferase 1
disease_progression
ISO
protein:increased expression:pancreas CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:29844410 PMID:19424621
RGD:9588974
NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184
G
Dnmt3b
DNA methyltransferase 3B
disease_progression
ISO
RGD
PMID:22919364
RGD:9589121
NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650
G
Dtx1
deltex 1, E3 ubiquitin ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 5:120,818,268...120,850,879
Ensembl chr 5:120,818,267...120,849,992
G
Dtx4
deltex 4, E3 ubiquitin ligase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr19:12,443,700...12,479,509
Ensembl chr19:12,443,702...12,478,818
G
Egf
epidermal growth factor
disease_progression
ISO
protein:increased expression: :
RGD
PMID:18505086
RGD:2317644
NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965
G
Fasl
Fas ligand
ISO
protein:increased expression:pancreas, liver
RGD
PMID:10547193 PMID:15375495
RGD:2317747 , RGD:2317741
NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064
G
Fgf2
fibroblast growth factor 2
disease_progression
ISO
RGD
PMID:12717266 PMID:18704599
RGD:2317758 , RGD:2317756
NCBI chr 3:37,402,616...37,464,255
Ensembl chr 3:37,402,495...37,464,257
G
Fscn1
fascin actin-bundling protein 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:12109856
RGD:2317790
NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940
G
Gpnmb
glycoprotein (transmembrane) nmb
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr 6:49,013,449...49,044,413
Ensembl chr 6:49,013,480...49,047,863
G
Gstp1
glutathione S-transferase, pi 1
resistance
ISO
DNA:methylation: : mRNA, protein:increased expression:pancreas
RGD
PMID:16537562 PMID:17265526 PMID:12488200
RGD:2317809 , RGD:2317806 , RGD:2317811
NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985
G
Hdac1
histone deacetylase 1
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:19424621
RGD:9588974
NCBI chr 4:129,409,897...129,436,516
Ensembl chr 4:129,409,897...129,436,506
G
Heatr1
HEAT repeat containing 1
treatment
ISO
RGD
PMID:26676747
RGD:10761108
NCBI chr13:12,410,256...12,453,774
Ensembl chr13:12,409,908...12,455,170
G
Hes1
hes family bHLH transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr16:29,883,259...29,886,614
Ensembl chr16:29,883,202...29,886,614
G
Hey1
hairy/enhancer-of-split related with YRPW motif 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 3:8,728,419...8,732,098
Ensembl chr 3:8,728,419...8,732,316
G
Hey2
hairy/enhancer-of-split related with YRPW motif 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr10:30,708,355...30,718,779
Ensembl chr10:30,708,355...30,718,797
G
Hspa1a
heat shock protein 1A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr17:35,188,335...35,191,132
Ensembl chr17:35,188,166...35,191,132
G
Hspa1b
heat shock protein 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17234771
NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214
G
Igf1
insulin-like growth factor 1
IDA
RGD
PMID:20098680
RGD:2317639
NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904
G
Igf1r
insulin-like growth factor I receptor
ISO
protein:increased expression:pancreas
RGD
PMID:14506643 PMID:14627343
RGD:2317652 , RGD:2317649
NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416
G
Il4
interleukin 4
ISO
RGD
PMID:17942922
RGD:2317264
NCBI chr11:53,503,287...53,509,492
Ensembl chr11:53,493,809...53,509,496
G
Il4ra
interleukin 4 receptor, alpha
ISO
protein:increased expression:pancreas
RGD
PMID:17942922
RGD:2317264
NCBI chr 7:125,151,443...125,178,646
Ensembl chr 7:125,151,292...125,178,646
G
Ins2
insulin II
ISO
Glucagon/insulin
RGD
PMID:19571666
RGD:2317248
NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118
G
Jag1
jagged 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564
G
Jag2
jagged 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr12:112,871,439...112,893,437
Ensembl chr12:112,871,439...112,893,396
G
Kdm2b
lysine (K)-specific demethylase 2B
severity
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:23321669
RGD:9588253
NCBI chr 5:123,008,727...123,127,333
Ensembl chr 5:123,008,728...123,127,886
G
Kitl
kit ligand
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr10:99,851,477...99,936,278
Ensembl chr10:99,851,492...99,936,278
G
Kras
Kirsten rat sarcoma viral oncogene homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:25347530 PMID:30654191
NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965
G
Krt7
keratin 7
disease_progression
ISO
RGD
PMID:19260470
RGD:2317307
NCBI chr15:101,310,284...101,325,687
Ensembl chr15:101,308,924...101,328,194
G
L1cam
L1 cell adhesion molecule
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:20162456
RGD:6483447
NCBI chr X:72,897,384...72,924,843
Ensembl chr X:72,897,384...72,939,711
G
Map3k7
mitogen-activated protein kinase kinase kinase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 4:31,963,659...32,023,470
Ensembl chr 4:31,964,097...32,023,467
G
Mapk3
mitogen-activated protein kinase 3
treatment
ISO
human cells in mouse model
RGD
PMID:20179210
RGD:14348973
NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991
G
Mcm7
minichromosome maintenance complex component 7
ISO
mRNA, protein:increased expression:pancreatic duct
RGD
PMID:15548371
RGD:2317697
NCBI chr 5:138,162,845...138,170,675
Ensembl chr 5:138,162,845...138,170,684
G
Mdm2
transformed mouse 3T3 cell double minute 2
severity onset
ISO
protein:increased expression:pancreas (human) DNA:snp:promoter, intron:IVS1+309T>G (human)
RGD
PMID:15810085 PMID:19752772
RGD:2317416 , RGD:2317414
NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663
G
Men1
multiple endocrine neoplasia 1
ISO
protein:decreased expression:pancreas
RGD
PMID:19170121
RGD:2317294
NCBI chr19:6,385,009...6,390,924
Ensembl chr19:6,385,009...6,390,921
G
Met
met proto-oncogene
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:7866999
RGD:2317530
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mgmt
O-6-methylguanine-DNA methyltransferase
susceptibility
ISO
DNA:missense mutation:cds:p.L84F rs12917 (human) protein:increased activity, increased expression:ductal adenocarcinoma (human)
RGD
PMID:16844323 PMID:9393761
RGD:2317648 , RGD:2317664
NCBI chr 7:136,496,315...136,732,001
Ensembl chr 7:136,496,343...136,731,995
G
Mir142
microRNA 142
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr11:87,647,690...87,647,753
Ensembl chr11:87,647,690...87,647,753
G
Mir873a
microRNA 873a
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:30654191
NCBI chr 4:36,668,510...36,668,586
Ensembl chr 4:36,668,510...36,668,586
G
Mmp2
matrix metallopeptidase 2
severity
ISO
protein:increased expression:pancreas
RGD
PMID:17377415
RGD:2325746
NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:pancreas, serum protein:increased expression:blood
RGD
PMID:18706098 PMID:20332475
RGD:2325844 , RGD:2325830
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Msln
mesothelin
disease_progression
ISO
protein:increased secretion:serum CTD Direct Evidence: marker/mechanism DNA:hypomethylation:5'UTR
CTD RGD
PMID:14576474 PMID:21775916 PMID:25347530 PMID:19818733 PMID:12874021
RGD:2326055 , RGD:2326065
NCBI chr17:25,967,587...25,973,352
Ensembl chr17:25,967,587...25,973,352
G
Muc1
mucin 1, transmembrane
disease_progression
ISO
protein:increased expression, altered localization:pancreas
RGD
PMID:18713982 PMID:14681945 PMID:19109152
RGD:2324633 , RGD:2317983 , RGD:2324616
NCBI chr 3:89,136,363...89,140,688
Ensembl chr 3:89,136,364...89,140,688
G
Muc3a
mucin 3A, cell surface associated
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:12657964
RGD:2324946
NCBI chr 5:137,243,263...137,276,564
Ensembl chr 5:137,243,270...137,246,852
G
Muc4
mucin 4
disease_progression
ISO
mRNA:increased expression:pancreas protein:increased expression:pancreas
RGD
PMID:12657964 PMID:16049287
RGD:2324946 , RGD:2324942
NCBI chr16:32,555,089...32,602,786
Ensembl chr16:32,555,015...32,602,754
G
Muc5ac
mucin 5, subtypes A and C, tracheobronchial/gastric
disease_progression
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125 PMID:10227724
RGD:2324986 , RGD:2324907
NCBI chr 7:141,342,695...141,372,964
Ensembl chr 7:141,342,709...141,372,968
G
Muc5b
mucin 5, subtype B, tracheobronchial
ISO
mRNA:increased expression:pancreas
RGD
PMID:7657125
RGD:2324986
NCBI chr 7:141,392,796...141,426,826
Ensembl chr 7:141,392,807...141,426,821
G
Ndrg1
N-myc downstream regulated gene 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16778198
NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489
G
Nfe2l2
nuclear factor, erythroid derived 2, like 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21489257
NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985
G
Nme1
NME/NM23 nucleoside diphosphate kinase 1
ISO
protein:increased expression:pancreas (human)
RGD
PMID:17492507
RGD:5132867
NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347
G
Nos2
nitric oxide synthase 2, inducible
IMP
RGD
PMID:12660813
RGD:2325254
NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080
G
Notch1
notch 1
IMP ISO
CTD Direct Evidence: marker/mechanism
CTD RGD
PMID:19208345 PMID:20484026 PMID:19028876
RGD:2325323 , RGD:2325324
NCBI chr 2:26,347,914...26,393,834
Ensembl chr 2:26,347,915...26,406,675
G
Notch3
notch 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826
G
Notch4
notch 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:19208345
NCBI chr17:34,783,257...34,807,517
Ensembl chr17:34,783,242...34,807,477
G
Ntrk3
neurotrophic tyrosine kinase, receptor, type 3
disease_progression
ISO
protein:increased expression:pancreas
RGD
PMID:11295066 PMID:10209957
RGD:2325660 , RGD:2325663
NCBI chr 7:77,825,711...78,228,865
Ensembl chr 7:77,825,707...78,387,760
G
Osm
oncostatin M
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:24979617
NCBI chr11:4,186,831...4,191,027
Ensembl chr11:4,186,420...4,191,026
G
Palld
palladin, cytoskeletal associated protein
ISO
protein:increased expression, alternative form:pancreas, fibroblast
RGD
PMID:17404500
RGD:2325781
NCBI chr 8:61,964,465...62,355,741
Ensembl chr 8:61,964,467...62,355,724
G
Pax6
paired box 6
ISO
protein:increased expression:pancreatic duct (human)
RGD
PMID:17849422
RGD:8552381
NCBI chr 2:105,499,241...105,528,755
Ensembl chr 2:105,499,245...105,527,709
G
Pms1
postmeiotic segregation increased 1 (S. cerevisiae)
ISO
protein:increased expression:pancreatic duct
RGD
PMID:15856462
RGD:2324870
NCBI chr 1:53,225,794...53,336,190
Ensembl chr 1:53,228,346...53,336,177
G
Pparg
peroxisome proliferator activated receptor gamma
disease_progression
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360
G
Ptgs2
prostaglandin-endoperoxide synthase 2
IMP
RGD
PMID:18670639
RGD:2317185
NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978
G
Rela
v-rel reticuloendotheliosis viral oncogene homolog A (avian)
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158
G
Rnf2
ring finger protein 2
IEP
protein:increased expression:pancreas
RGD
PMID:19585519
RGD:9491843
NCBI chr 1:151,345,159...151,376,562
Ensembl chr 1:151,333,755...151,376,706
G
Rxra
retinoid X receptor alpha
severity
ISO
RGD
PMID:19396032
RGD:2317461
NCBI chr 2:27,566,457...27,653,331
Ensembl chr 2:27,566,452...27,652,969
G
Serpina1e
serine (or cysteine) peptidase inhibitor, clade A, member 1E
ISO
mRNA, protein:increased expression:pancreas
RGD
PMID:12488200
RGD:2317811
NCBI chr12:103,913,190...103,923,156
Ensembl chr12:103,913,190...103,925,234
G
Slc2a2
solute carrier family 2 (facilitated glucose transporter), member 2
IEP
protein:increased expression:pancreatic duct
RGD
PMID:19252908
RGD:2324975
NCBI chr 3:28,752,052...28,782,510
Ensembl chr 3:28,752,052...28,785,508
G
Smad4
SMAD family member 4
disease_progression
ISO
RGD
PMID:15173084
RGD:21066334
NCBI chr18:73,767,861...73,836,862
Ensembl chr18:73,772,080...73,836,851
G
Smo
smoothened, frizzled class receptor
ISO
RGD
PMID:16826192
RGD:2324981
NCBI chr 6:29,735,480...29,761,359
Ensembl chr 6:29,735,502...29,761,364
G
Stk11
serine/threonine kinase 11
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:26887594
NCBI chr10:79,951,602...79,966,513
Ensembl chr10:79,951,637...79,966,516
G
Tgfb1
transforming growth factor, beta 1
disease_progression
ISO
RGD
PMID:16101174
RGD:2325019
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfbr2
transforming growth factor, beta receptor II
disease_progression
IMP ISO
mRNA:increased expresssion:pancreas
RGD
PMID:17114585 PMID:10547197
RGD:2317498 , RGD:2317500
NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428
G
Thbs1
thrombospondin 1
disease_progression
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:12429967 PMID:19065635
RGD:2325025 , RGD:2325022
NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614
G
Tmprss3
transmembrane protease, serine 3
ISO
RGD
PMID:14695172
RGD:2325152
NCBI chr17:31,398,237...31,419,478
Ensembl chr17:31,398,239...31,417,951
G
Trp53
transformation related protein 53
EXP
CTD Direct Evidence: marker/mechanism
CTD
PMID:29844410
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
G
Tsc2
TSC complex subunit 2
severity
ISO
RGD
PMID:16213898
RGD:11568674
NCBI chr17:24,814,788...24,851,607
Ensembl chr17:24,814,790...24,851,604
G
Tymp
thymidine phosphorylase
disease_progression
ISO
RGD
PMID:19760965
RGD:2325155
NCBI chr15:89,255,834...89,261,282
Ensembl chr15:89,256,134...89,261,242
G
Vegfa
vascular endothelial growth factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17481528
NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295
G
Vhl
von Hippel-Lindau tumor suppressor
ISO
DNA:hypermethylation:promoter (human)
RGD
PMID:19065635
RGD:2325022
NCBI chr 6:113,600,955...113,608,595
Ensembl chr 6:113,600,920...113,608,594
G
Yeats2
YEATS domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr16:19,959,803...20,051,323
Ensembl chr16:19,959,813...20,051,323
G
Zzz3
zinc finger, ZZ domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:34686948
NCBI chr 3:152,101,110...152,168,463
Ensembl chr 3:152,101,110...152,168,463
G
Tgfb2
transforming growth factor, beta 2
ameliorates
ISO
human cells in a mouse model
RGD
PMID:21366804
RGD:155630611
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Agr2
anterior gradient 2
ISO
protein:increased expression:pancreas
RGD
PMID:19714807
RGD:2325658
NCBI chr12:36,042,924...36,054,080
Ensembl chr12:36,042,906...36,054,086
G
Akr7a5
aldo-keto reductase family 7, member A5
ISO
protein:increased expression:pancreas
RGD
PMID:19077459
RGD:2325696
NCBI chr 4:139,038,005...139,046,097
Ensembl chr 4:139,038,055...139,045,737
G
Calr
calreticulin
ameliorates
ISO
human cells in mouse model human cells in a mouse model
RGD
PMID:33028359 PMID:29072694
RGD:150520160 , RGD:150521706
NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563
G
Ccnd1
cyclin D1
severity
ISO
DNA:snp:exon:c.870G>A (human) protein:increased expression:pancreas (human)
RGD
PMID:25470788 PMID:22939953
RGD:13462050 , RGD:13462062
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cd59b
CD59b antigen
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 2:103,900,127...103,920,619
Ensembl chr 2:103,896,142...103,921,534
G
Cdk4
cyclin dependent kinase 4
severity
ISO
protein:increased expression:pancreas, islet of Langerhans (human)
RGD
PMID:29735403
RGD:13781899
NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789
G
Cfhr2
complement factor H-related 2
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 1:139,738,030...139,786,437
Ensembl chr 1:139,731,905...139,786,456
G
E2f1
E2F transcription factor 1
severity
ISO
protein:increased expression:pancreatic ductal cell, nucleus (human) DNA:amplification: : (human)
RGD
PMID:12650514 PMID:17233815 PMID:27573434
RGD:13838735 , RGD:13838739 , RGD:13838738
NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812
G
Foxm1
forkhead box M1
disease_progression
ISO
RGD
PMID:24859161
RGD:156430321
NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109
G
Fubp1
far upstream element (FUSE) binding protein 1
ISO
mRNA:increased expression:pancreatic duct (human)
RGD
PMID:32481602
RGD:151361197
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
Glipr2
GLI pathogenesis-related 2
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 4:43,957,702...43,979,118
Ensembl chr 4:43,957,401...43,979,118
G
Got1
glutamic-oxaloacetic transaminase 1, soluble
treatment
ISO
human cells in a mouse model
RGD
PMID:23535601
RGD:13504844
NCBI chr19:43,488,191...43,514,743
Ensembl chr19:43,488,191...43,513,044
G
Hspa8
heat shock protein 8
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 9:40,712,572...40,716,498
Ensembl chr 9:40,712,280...40,721,383
G
Ikbkb
inhibitor of kappaB kinase beta
susceptibility
IMP
RGD
PMID:22264792
RGD:13838741
NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605
G
Jak1
Janus kinase 1
ISO
mRNA:decreased expression:pancreatic ductal cell (human)
RGD
PMID:28677798
RGD:13838745
NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479
G
Mapk8
mitogen-activated protein kinase 8
severity disease_progression
IMP IEP
protein:increased phosphorylation:pancreas (mouse)
RGD
PMID:28837246 PMID:23237571
RGD:14348974 , RGD:14348975
NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115
G
Mir155
microRNA 155
disease_progression
ISO
RGD
PMID:28198398
RGD:25314300
NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092
G
Mir494
microRNA 494
disease_progression ameliorates
ISO
RGD
PMID:24859161 PMID:24859161
RGD:156430321 , RGD:156430321
NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836
G
Pgf
placental growth factor
severity
IMP
associated with obesity
RGD
PMID:26861455
RGD:14349030
NCBI chr12:85,213,413...85,224,087
Ensembl chr12:85,213,409...85,224,564
G
Pik3cg
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma
ISO
mRNA, protein:increased expression:pancreas (human)
RGD
PMID:20876794
RGD:14390130
NCBI chr12:32,223,128...32,258,675
Ensembl chr12:32,223,472...32,258,658
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
severity
ISO
human cells in a mouse model
RGD
PMID:15591514
RGD:14390084
NCBI chr 8:71,220,820...71,229,356
Ensembl chr 8:71,220,820...71,229,357
G
Pld1
phospholipase D1
severity
ISO
protein:increased expression:pancreas (human)
RGD
PMID:27713167
RGD:14392801
NCBI chr 3:27,992,636...28,187,388
Ensembl chr 3:27,992,844...28,187,511
G
Ptprb
protein tyrosine phosphatase receptor type B
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr10:116,111,407...116,225,443
Ensembl chr10:116,111,428...116,225,440
G
Ptprm
protein tyrosine phosphatase receptor type M
disease_progression
ISO
protein:decreased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr17:66,973,843...67,661,486
Ensembl chr17:66,973,942...67,661,452
G
Rac1
Rac family small GTPase 1
ISO IEP
mRNA:increased expression:pancreas (human) mRNA, protein:increased expression:pancreas (mouse)
RGD
PMID:23334332 PMID:21684285
RGD:14392806 , RGD:14392816
NCBI chr 5:143,491,236...143,513,786
Ensembl chr 5:143,489,389...143,513,791
G
Rala
v-ral simian leukemia viral oncogene A (ras related)
ISO
mRNA:increased expression:pancreas (human)
RGD
PMID:29113235
RGD:14394418
NCBI chr13:18,055,160...18,118,802
Ensembl chr13:18,055,156...18,118,824
G
S100a8
S100 calcium binding protein A8 (calgranulin A)
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342
G
Smad2
SMAD family member 2
severity
ISO
RGD
PMID:26908446
RGD:14394493
NCBI chr18:76,369,898...76,444,819
Ensembl chr18:76,374,651...76,444,034
G
Tgfb1
transforming growth factor, beta 1
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502
G
Tgfb2
transforming growth factor, beta 2
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr 1:186,354,984...186,441,504
Ensembl chr 1:186,354,989...186,438,186
G
Tgfb3
transforming growth factor, beta 3
ameliorates
ISO
protein:decreased expression:pancreas (human)
RGD
PMID:8253361
RGD:155630628
NCBI chr12:86,103,517...86,125,815
Ensembl chr12:86,103,519...86,125,815
G
Tgfbr1
transforming growth factor, beta receptor I
ameliorates
ISO
human cell line in a mouse model
RGD
PMID:17297450
RGD:155630637
NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931
G
Vegfd
vascular endothelial growth factor D
ISO
protein:increased expression:blood serum (human)
RGD
PMID:21410412
RGD:155630646
NCBI chr X:163,156,282...163,185,643
Ensembl chr X:163,156,374...163,185,646
G
Vnn1
vanin 1
disease_progression
ISO
protein:increased expression:blood (human)
RGD
PMID:32663515
RGD:151660329
NCBI chr10:23,770,586...23,781,242
Ensembl chr10:23,770,586...23,781,241
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all